• The ocular pharmacokinetics of saperconazole, an experimental lipophilic triazole with activity against filamentous fungi, including Aspergillus and Candida species, were evaluated in rabbits by radioassay. The drug was administered by topical, subconjunctival, and oral routes. Following a single 20-μL drop of 0.25% saperconazole in normal corneas, a mean (±SEM) peak level of 2.32±0.06 μg/g was achieved in 10 minutes. In débrided corneas, a peak level of 13.09±2.87 μg/g was achieved in 2 minutes. The drug was rapidly cleared from the cornea within 2 hours. The administration of 13 drops during 1 hour resulted in a threefold increase in normal corneal levels and in a sixfold increase in débrided cornea levels. Peak levels following subconjunctival injection in normal corneas (12.91±2.02 μg/g) were approximately twofold greater than those following sustained topical administration (6.19±0.16 μg/g) and, in débrided corneas, were a third higher than those following topical therapy in débrided corneas. Clearance was virtually complete by 8 hours. Levels following oral administration were low and probably subtherapeutic in all ocular tissues that were evaluated. Bioassay studies revealed that 44.17% of the drug in the cornea following topical administration was bioactive.
O'Day DM, Head WS, Robinson RD, Williams TE, Wolff R. Ocular Pharmacokinetics of Saperconazole in Rabbits: A Potential Agent Against Keratomycoses. Arch Ophthalmol. 1992;110(4):550–554. doi:10.1001/archopht.1992.01080160128050
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: